Why the study?
Hyponatremia predicts worse acute outcomes in COVID-19, but whether early hyponatremia is also a predictor of long-term sequelae at follow-up was unknown.
Does hyponatremia at hospital admission predict worse cardiopulmonary profile at 6-month follow-up in patients with COVID-19?
Does hyponatremia at hospital admission predict worse cardiopulmonary profile at 6-month follow-up in patients with COVID-19?
Early hyponatremia in COVID-19 patients is associated with greater pulmonary and right-sided heart involvement at 6-month follow-up.
May flag COVID-19 patients for closer cardiopulmonary surveillance; leaves open prognostic value and need for prospective validation.
PURPOSE: Hyponatremia occurs in about 30% of patients with pneumonia, including those with SARS-CoV-2 (COVID-19) infection. Hyponatremia predicts a worse outcome in several pathologic conditions and in COVID-19 has been associated with a higher risk of non-invasive ventilation, ICU transfer and death. The main objective of this study was to determine whether early hyponatremia is also a predictor of long-term sequelae at follow-up. METHODS: In this observational study, we collected 6-month follow-up data from 189 laboratory-confirmed COVID-19 patients previously admitted to a University Hospital. About 25% of the patients (n = 47) had hyponatremia at the time of hospital admission. RESULTS: increased. Accordingly, pulmonary involvement, evaluated at the chest X-ray by the RALE score, decreased. However, in patients with hyponatremia at hospital admission, higher levels of LDH, fibrinogen, troponin T and NT-ProBNP were detected at follow-up, compared to patients with normonatremia at admission. In addition, hyponatremia at admission was associated with worse echocardiography parameters related to right ventricular function, together with a higher RALE score. CONCLUSION: These results suggest that early hyponatremia in COVID-19 patients is associated with the presence of laboratory and imaging parameters indicating a greater pulmonary and right-sided heart involvement at follow-up.
No takes yet. Share an insight, caveat, or question.
Malandrino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: